Soricimed Biopharma Inc (Soricimed Biopharma), formerly BioProspecting NB Inc is a drug and diagnostic developer that offers pain management solutions. The company offers services such as development and commercialization of therapeutic and diagnostic programs. Its oncology management platform arises from the ability of soricidin and the C-series peptides to modulate the activity of a calcium ion channel. Soricimed Biopharma’s products are used in the treatment of breast cancer, ovarian cancer, and prostate cancer, and other cancer types. The company operates through a network of contract research organizations that provide research outside its core capacities. Soricimed Biopharma is headquartered in Moncton, New Brunswick, Canada.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope
Reasons to buy
Note: Some sections may be missing if data is unavailable for the company
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Soricimed Biopharma Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Soricimed Biopharma Inc Company Overview
- Soricimed Biopharma Inc Company Snapshot
- Soricimed Biopharma Inc Pipeline Products and Ongoing Clinical Trials Overview
- Soricimed Biopharma Inc - Pipeline Analysis Overview
- Soricimed Biopharma Inc - Key Facts
- Soricimed Biopharma Inc - Major Products and Services
- Soricimed Biopharma Inc Pipeline Products by Development Stage
- Soricimed Biopharma Inc Pipeline Products Overview
- Diagnostic SOR-D01 Assay - Breast Cancer
- Diagnostic SOR-D01 Assay - Breast Cancer Product Overview
- Diagnostic SOR-D01 Assay - Ovarian Cancer
- Diagnostic SOR-D01 Assay - Ovarian Cancer Product Overview
- Diagnostic SOR-D01 Assay - Prostate Cancer
- Diagnostic SOR-D01 Assay - Prostate Cancer Product Overview
- Diagnostic SOR-D02 Assay - Breast Cancer
- Diagnostic SOR-D02 Assay - Breast Cancer Product Overview
- Diagnostic SOR-D02 Assay - Ovarian Cancer
- Diagnostic SOR-D02 Assay - Ovarian Cancer Product Overview
- Diagnostic SOR-D02 Assay - Prostate Cancer
- Diagnostic SOR-D02 Assay - Prostate Cancer Product Overview
- Soricimed Biopharma Inc - Key Competitors
- Soricimed Biopharma Inc - Key Employees
- Soricimed Biopharma Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- Soricimed Biopharma Inc, Recent Developments
- Mar 19, 2018: Soricimed Appoints Dr. Marc Rubin And Mr. Vaughn Embro-Pantalony As Board Directors
- Jan 26, 2016: Soricimed Welcomes Bob Cory, PhD, to Executive Team and Appoints Tom Reeves to Chair
- May 06, 2015: Soricimed’s Findings Support TRPV6 as a Novel and Significant Biomarker for Ovarian Cancer-Targeted Therapies and Diagnostics
- Mar 18, 2014: Soricimed Biopharma Announces New VP of R&D
- Nov 09, 2012: Soricimed CEO Builds BioTech in New Brunswick. CEO Paul Gunn presents innovative business model at NBHRF
- Oct 23, 2012: Soricimed Biopharma Announces Initiation of Cancer Diagnostic Study With Potential To Detect Stage One Cancer
- Oct 23, 2012: Soricimed Announces Initiation Of Cancer Diagnostic Study With Potential To Detect Stage One Cancer
- Appendix
- Methodology
- About
- Contact
- Disclaimer
List of Tables
- Soricimed Biopharma Inc Pipeline Products and Ongoing Clinical Trials Overview
- Soricimed Biopharma Inc Pipeline Products by Equipment Type
- Soricimed Biopharma Inc Pipeline Products by Indication
- Soricimed Biopharma Inc, Key Facts
- Soricimed Biopharma Inc, Major Products and Services
- Soricimed Biopharma Inc Number of Pipeline Products by Development Stage
- Soricimed Biopharma Inc Pipeline Products Summary by Development Stage
- Diagnostic SOR-D01 Assay - Breast Cancer - Product Status
- Diagnostic SOR-D01 Assay - Breast Cancer - Product Description
- Diagnostic SOR-D01 Assay - Ovarian Cancer - Product Status
- Diagnostic SOR-D01 Assay - Ovarian Cancer - Product Description
- Diagnostic SOR-D01 Assay - Prostate Cancer - Product Status
- Diagnostic SOR-D01 Assay - Prostate Cancer - Product Description
- Diagnostic SOR-D02 Assay - Breast Cancer - Product Status
- Diagnostic SOR-D02 Assay - Breast Cancer - Product Description
- Diagnostic SOR-D02 Assay - Ovarian Cancer - Product Status
- Diagnostic SOR-D02 Assay - Ovarian Cancer - Product Description
- Diagnostic SOR-D02 Assay - Prostate Cancer - Product Status
- Diagnostic SOR-D02 Assay - Prostate Cancer - Product Description
- Soricimed Biopharma Inc, Key Employees
- Glossary
List of Figures
- Soricimed Biopharma Inc Pipeline Products by Equipment Type
- Soricimed Biopharma Inc Pipeline Products by Development Stage
Samples
LOADING...
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- WEX Pharmaceuticals Inc
- MaRS Innovation
- NovaBioMed Inc
